NEJM Interview: Kushal Kadakia on the 21st Century Cures Act, Cures 2.0, and lessons from Covid-19 for medical product development.
NEJM Interviews
00:00
Introduction
The 20 first century cures act, which passed in 20 16, was intended to accelerate medical product development by elevating digital research strategies and the use of real world evidence. In 20 21, legislators introduced the follow up cures two point o act. The fundamental policy question underlying both pieces of legislation is how to accelerate discovery without jeopardizing safety.
Play episode from 00:00
Transcript
